← Eichor
Study identifier: NCT05285345 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Condition: Bronchopulmonary Dysplasia  ·  Sponsor: Boston Children's Hospital

PhaseN/A
Planned participants50
Who can joinAll sexes, 0 Days to 1 Year
Healthy volunteersNo

About this study

The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants with lung disease around discharge from the neonatal intensive care unit to home. This study looks to evaluate implementation of the recommendations at Boston Children's Hospital and referring NICU's (Beth Israel Deaconess Medical Center and Brigham and Women's Hospital). Specifically, the research team will be looking at follow-up rates, healthcare utilization, and parental satisfaction/feedback with implementation of these guidelines.

This description comes directly from the study's public registry record.

Talk to the study team

Jonathan Levin, MD  ·  617-355-1900  ·  jonathan.levin@childrens.harvard.edu

Vanessa J Young  ·  617-355-8330  ·  vanessa.young@childrens.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Boston Children's HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05285345